BridgeBio Pharma Inc (NASDAQ:BBIO)

25.91
Delayed Data
As of Sep 13
 -0.19 / -0.73%
Today’s Change
24.06
Today|||52-Week Range
32.94
--
Year-to-Date

Today’s Trading

Previous close26.10
Today’s open26.09
Day’s range25.33 - 26.53
Volume194,077
Average volume (3 months)324,369
Market cap$3.0B
Data as of 4:00pm ET, 09/13/2019

Growth & Valuation

Earnings growth (last year)-278.84%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
AKRXAkorn Inc-0.10-2.67%
TEVATeva Pharmaceutical-0.24-2.93%
BGNEBeiGene Ltd+1.10+0.83%
Data as of 6:30pm ET, 09/13/2019

Financials

Next reporting dateNovember 27, 2019
EPS forecast (this quarter)-$0.96
Annual revenue (last year)$0.00
Annual profit (last year)-$130.7M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
SVP- Asset Acquisition, Strategy &
Operations
Michael Henderson
Chief Financial Officer
Brian C. Stephenson
Corporate headquarters
Palo Alto, California

Forecasts